OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance
Victor S.C. Fung, Jason Aldred, Martha P. Arroyo, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 10, pp. 100239-100239
Open Access | Times Cited: 9
Victor S.C. Fung, Jason Aldred, Martha P. Arroyo, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 10, pp. 100239-100239
Open Access | Times Cited: 9
Showing 9 citing articles:
Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report
Tomonori Nukariya, Toshiki Tezuka, Shohei Okusa, et al.
Journal of Movement Disorders (2025)
Open Access | Times Cited: 1
Tomonori Nukariya, Toshiki Tezuka, Shohei Okusa, et al.
Journal of Movement Disorders (2025)
Open Access | Times Cited: 1
Neutrophil‐Rich Infusion Site Reactions After Continuous Subcutaneous Application of Foslevodopa/Foscarbidopa
David Weise, Sebastian Haferkamp
Movement Disorders (2025)
Open Access | Times Cited: 1
David Weise, Sebastian Haferkamp
Movement Disorders (2025)
Open Access | Times Cited: 1
Subcutaneous Levodopa: A New Engine for the Vintage Molecule
Karolina Popławska-Domaszewicz, Lucia Batzu, Cristian Falup‐Pecurariu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1055-1068
Open Access | Times Cited: 7
Karolina Popławska-Domaszewicz, Lucia Batzu, Cristian Falup‐Pecurariu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1055-1068
Open Access | Times Cited: 7
What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience
Onanong Phokaewvarangkul, Manon Auffret, Sergiu Groppa, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 11, pp. 1307-1320
Closed Access | Times Cited: 5
Onanong Phokaewvarangkul, Manon Auffret, Sergiu Groppa, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 11, pp. 1307-1320
Closed Access | Times Cited: 5
20-Week Toxicity Study of Rotigotine Behenate Extended-Release Microspheres for Intramuscular Injection in Sprague Dawley Rats
Wenjing Lv, Hong Zhang, Yumeng Chen, et al.
Food and Chemical Toxicology (2025), pp. 115384-115384
Closed Access
Wenjing Lv, Hong Zhang, Yumeng Chen, et al.
Food and Chemical Toxicology (2025), pp. 115384-115384
Closed Access
Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease
Sacha Brohée, Emmanuel Roze, David Grabli, et al.
Movement Disorders Clinical Practice (2025)
Open Access
Sacha Brohée, Emmanuel Roze, David Grabli, et al.
Movement Disorders Clinical Practice (2025)
Open Access
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson’s Disease
Hannah A. Blair
CNS Drugs (2025)
Closed Access
Hannah A. Blair
CNS Drugs (2025)
Closed Access
Potential Psychosis Induced by Sustained High Plasma Levodopa Concentration via Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson’s Disease: A Case Report
Toshiki Tezuka, Tomonori Nukariya, Yuta Kizuka, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 4, pp. 453-455
Open Access | Times Cited: 1
Toshiki Tezuka, Tomonori Nukariya, Yuta Kizuka, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 4, pp. 453-455
Open Access | Times Cited: 1
A patient with Parkinson’s disease whose sleep status improved after the introduction of continuous subcutaneous foslevodopa/foscarbidopa infusion
Hirotaka Sakuramoto, Hiroaki Fujita, Keitaro Ogaki, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100292-100292
Open Access | Times Cited: 1
Hirotaka Sakuramoto, Hiroaki Fujita, Keitaro Ogaki, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100292-100292
Open Access | Times Cited: 1
Maladie de Parkinson : traitements par dispositifs, stimulation dopaminergique continue
Marc Vérin, Manon Auffret
EMC - Neurologie (2024) Vol. 47, Iss. 4, pp. 1-11
Closed Access
Marc Vérin, Manon Auffret
EMC - Neurologie (2024) Vol. 47, Iss. 4, pp. 1-11
Closed Access
